WHO ICTRP trial
Long-term study of KRP-108
JPRN-jRCT2080223577 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080223577 |
|---|---|
| Public title | Long-term study of KRP-108 |
| Scientific title | Phase III long-term study of KRP-108 -open-label, non-controlled, long-term study of KRP-108 in pediatric bronchial asthma- |
| Primary sponsor | Kyorin Pharmaceutical Co.,LTD |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan |
| Conditions | Bronchial asthma |
| Interventions | investigational material(s) Generic name etc : KRP-108 INN of investigational material : Fluticasone/Formoterol Therapeutic category code : 229 Other agents affecting respiratory organs Dosage and Administration for Investigational material… |
| Registration date | Jun 28, 2017 |
| Target size | 40 |
| Secondary IDs | JapicCTI-173633 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: